LifeStance Health stockholders launch 45 million-share secondary offering
LFST•LifeStance Health Group stockholders plan to sell 45 million common shares in a secondary offering, with all proceeds going to the sellers. The company plans to repurchase 2 million shares from underwriters at the price paid to selling stockholders, subject to completion.
1. Offering details
Selling stockholders will receive all proceeds, and LifeStance Health Group will not sell shares or receive proceeds. The company plans to repurchase 2 million shares from underwriters at the price they pay the selling stockholders, subject to completion of the offering; underwriters will receive no fees on those shares, and the offering is not contingent on the repurchase. Barclays and J.P. Morgan are underwriting the offering.
